Skip to main content
MDPediatrix Medical Group, Inc.Hold5.3·$28.91
HoldModerate Confidence
Investment thesis

Pediatrix trades at a low forward multiple of 10.3x with a PEG of 0.21 and peer-leading margins, but deeply overbought conditions at an RSI of 90, a stock price already above the technical resistance target, and a recent officer-level change create a poor setup for new buyers despite the fundamental appeal.

Thesis pillars

  • Compelling Fundamental Valuation→Stable
  • Earnings Momentum With Recent Stumble↓Deteriorating
  • Severely Overbought Above Resistance↓Deteriorating
  • +1 more pillar — see the Why tab for full reasoning

Pillars as of Jul 3, 2026, based on the 10-K filed Feb 19, 2026

Full reasoning →

Open full analysis

Pediatrix Medical Group, Inc. (MD) Stock Analysis

HoldValueQualityModerate Confidence

Healthcare · Medical Care Facilities

Hold if already holding. Not a fresh buy at $28.91, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Near 52-week high (3.8% away).

Pediatrix Medical Group operates a national network of approximately 2,295 affiliated physicians providing neonatal, maternal-fetal, and other pediatric subspecialty care at over 360 NICUs and 60 PICUs across 37 states. The company generates revenue through fee-for-service... Read more

$28.91-20.8% A.UpsideScore 5.3/10#24 of 35 Medical Care Facilities
QualityF-score7 / 9FCF yield6.84%
Stop $27.27Analyst target $22.91(reached)A.R:R -1.7:1
Analyst consensus$26.33-8.9%6 analysts
$28.91price
$26.33mean
$21

Hold if already holding. Not a fresh buy at $28.91, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Near 52-week high (3.8% away). Chart setup: No clear chart pattern; technical signals are mixed. Multiple concerning factors. Consider reducing position. | News modifier +1 (SELL_IF_HOLDING → HOLD_IF_HOLDING) Score 5.3/10, moderate confidence.

Passes 6/9 gates (positive momentum, clean insider activity, news events none recent, earnings proximity no date, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: aggressive.

news + 30-day 8-K events · 5-min refresh

Recent developments

updated 2026-10-29
TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Thu, Oct 29, 2026Date unconfirmed· next earnings call

Thesis

Rewards
Sector modifier (Healthcare): +0.5
Positive news sentiment (+0.67)
Attractive valuation
Risks
Analyst target reached - limited upside remaining
Near 52-week high (3.8% away)
V7 low-quality RISK_OFF penalty: -0.5 (Q=5.3)

Key Metrics

P/E (TTM)13.8
P/E (Fwd)11.8
Mkt Cap$2.3B
EV/EBITDA9.5
Profit Mgn9.0%
ROE20.4%
Rev Growth4.0%
Beta0.61
DividendNone
Rating analysts15

Quality Signals

Piotroski F7/9MoatNarrow

Options Flow

P/C1.20bearish
IV86%elevated

Concentration Risks(10-K Item 1A)

  • MEDIUMGeographicTexas32%
    10-K Item 1A: 'Texas accounted for approximately 32% of our net revenue in 2025'

Material Events(8-K, last 90d)

  • 2026-05-07Item 5.02LOW
    Shareholders approved Second Amended and Restated 2008 Incentive Compensation Plan at May 7, 2026 Annual Meeting, increasing shares available for issuance by 8,000,000. Administrative compensatory arrangement approval; no officer departure or appointment.
    SEC filing →

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results. How we score · Editorial policy

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. People who build TrendMatrix, or entities they control, may hold positions, long or short, in securities it covers, and may trade them at any time. Positions are not disclosed individually. Verdicts are generated by an automated model applied by the same rules to every covered stock, and are not adjusted for any position held by the people who build TrendMatrix. We do not accept payment from issuers for coverage.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

1 floor-breaker

Growth below the gate floor. Component breakdown shows what dragged the score down.static

Earnings Growth
3.3
Revenue Growth
3.5
GatesA.R:R -1.7=NEGATIVEMomentum 5.4<5.5 (soft — BUY_NOW allowed but watch)Executive change: officer departure/appointmentMomentum 5.4>=4.5Insider activity: OKNEWS EVENTS NONE RECENTEARNINGS PROXIMITY NO DATESEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARSuitability: Aggressive
RSI
74 · Overbought
↑ 20D MA↑ 50D MA↑ 200D MAGOLDEN CROSSSupport $25.40Resistance $30.05

Price Targets

A.Upside-20.8%
A.R:R-1.7:1

Position Sizing

ConvictionNone
Suggested %0%
Max %0%
RegimeRisk-Off

Risk Alerts

! Target reached (-20.8% upside)
! News modifier +1: SELL_IF_HOLDING → HOLD_IF_HOLDING
! Negative risk/reward — downside exceeds upside

Earnings

B
B
M
M
2/4 beats
Next Earnings2026-10-29 (Date unconfirmed)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is MD stock a buy right now?

Hold if already holding. Not a fresh buy at $28.91, but acceptable to hold if already in. Reasons: Analyst target reached - limited upside remaining; Near 52-week high (3.8% away). Chart setup: No clear chart pattern; technical signals are mixed. Multiple concerning factors. Consider reducing position. | News modifier +1 (SELL_IF_HOLDING → HOLD_IF_HOLDING) Analyst target $22.91 reached (−20.8%), stop $27.27 (−6.0%), A.R:R -1.7:1. Score 5.3/10, moderate confidence.

What is the MD stock price target?

Analyst target $22.91 reached (−20.8% from $28.91); no take-profit level is published. Analyst target $22.91 reached (−20.8%), stop $27.27 (−6.0%), A.R:R -1.7:1. Stop-loss: $27.27.

What are the risks of investing in MD?

Analyst target reached - limited upside remaining; Near 52-week high (3.8% away); V7 low-quality RISK_OFF penalty: -0.5 (Q=5.3).

Is MD overvalued or undervalued?

Pediatrix Medical Group, Inc. trades at a P/E of 13.8 (forward 11.8). TrendMatrix value score: 7.6/10. Verdict: Hold.

What do analysts say about MD?

15 analysts cover MD with a consensus score of 3.8/5. Average price target: $26.

What does Pediatrix Medical Group, Inc. do?Pediatrix Medical Group operates a national network of approximately 2,295 affiliated physicians providing neonatal,...

Pediatrix Medical Group operates a national network of approximately 2,295 affiliated physicians providing neonatal, maternal-fetal, and other pediatric subspecialty care at over 360 NICUs and 60 PICUs across 37 states. The company generates revenue through fee-for-service billings to commercial and government payers; Texas accounted for approximately 32% of net revenue in 2025.

Related stocks: SRTA (Strata Critical Medical, Inc.) · ASTH (Astrana Health Inc.) · AVAH (Aveanna Healthcare Holdings Inc) · CHE (Chemed Corp) · THC (Tenet Healthcare Corporation)
Home › Stocks › MD

Latest news

Latest News

MSN183d ago
Investing.com India21h agoEarnings
TradingView1d agoEarnings
Https://www.siam.in/8d ago
The American Journal of Managed Care8d ago
Investing.com Canada106d agoEarnings
Marketscreener.com106d agoEarnings
Yahoo Finance197d agoEarnings
MarketBeat197d ago
GuruFocus197d ago
Simplywall.st169d ago
Stock Titan169d ago
Indiana Daily Student169d ago
Insider Monkey169d ago
Yahoo Finance169d ago
GuruFocus169d ago
Montgomery County, MD (.gov)112d agoLegal
StockStory176d agoEarnings
Marketscreener.com85d agoAnalyst
Moomoo85d ago
Loading more...